ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2448

Flare Definitions for Juvenile Idiopathic Arthritis (JIA) Based on ACR Core Set Variables and Patient Reported Outcomes: Results from the Research in Arthritis in Canadian Children-Emphasizing Outcomes Prospective Cohort

Vinay Shivamurthy1, Deborah M. Levy2, Gilles Boire3, Karen N Watanabe Duffy4, Elizabeth Stringer5, Rosie Scuccimarri6, Rae S.M. Yeung7, Adam M. Huber8, Kiem Oen9, Natalie Shiff10, Lori B. Tucker11, Roberta Berard12, Kimberly Morishita13, Ciarán M. Duffy14 and Jaime Guzman15, 1Pediatrics/Rheumatology, British Columbia Children's Hospital, Vancouver, BC, Canada, 2Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 3Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, 4Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 5Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, 6Pediatrics, McGill University, Montréal, QC, Canada, 7Pediatrics, Immunology and Medical Science, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 8Pediatric rheumatology, IWK Health Centre, Halifax, NS, Canada, 9University of Manitoba, Winnipeg, MB, Canada, 10Pediatric Rheumatology, University of Saskatchewan, Saskatoon, SK, Canada, 11Rheumatology, BC Children's Hospital, Vancouver, BC, Canada, 12Children's Hospital of Western Ontario, London, ON, Canada, 13Pediatric Rheumatology, BC's Children's Hospital, Vancouver, BC, Canada, 14Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 15Rheumatology, Division of Rheumatology, BC Children's Hospital, Vancouver, BC, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Juvenile idiopathic arthritis-enthesitis (ERA) and outcomes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters (ACR): Imaging and Novel Clinical Interventions

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: A valid flare definition is needed in
clinical practice to identify a clinically relevant worsening which will guide
us make treatment decisions. While the ACR core variables are primarily
physician based criteria, patient reported variables could have a significant
role in helping patients identify worsening early and seek medical attention
sooner .Our aims were to 1) Examine the feasibility of using Patient Reported
Outcomes (PROs) and ACR core set variables to define flare in children with JIA
and 2) Examine the concordance between the two definitions

Methods: We studied children in the Research in Arthritis in
Canadian Children emphasizing outcomes (ReACCh-Out) prospective cohort. Data
were collected during routine clinical practice for newly diagnosed patients at
16 pediatric rheumatology centres enrolled between 2005 and 2010.  ACR core set
variables and patient reported variables were collected at 0, 6, 12, 18, 24,
36, 48 and 60 months after enrolment. The PROs included Pain visual analogue
scale, functional status measured by the Childhood Health Assessment
Questionnaire (CHAQ) and duration of morning stiffness.  Flare was defined as:
1) PROs flare: at least 30% worsening in 2/3 PROs with minimum duration for
stiffness of 30 minutes; 2) ACR Core Set flare: worsening of at least 3/6 ACR core
variables by at least 30% without concomitant improvement of more than one
variable by ≥ 30%. Flare status was assessed for each patient visit after
the subject attained clinically inactive disease. Concordance between the two
flare definitions was assessed with the Kappa statistic. The risk of first flare
was estimated by Kaplan-Meier survival analysis.

Results: A total of 1146 patients were included in the study
with a median follow up of 24 months after inactive disease.  Of the total 6177
study visits, 2358 visits occurred after patients had attained inactive
disease.  Imputation was required for missing data in 42 % of visits for ACR
core variables and 35 % for PROs.  After imputation the definition for flare
was fulfilled in 478 (20.2%) visits using ACR core variables and in 366 (15.5%)
visits using PRO variables. In 231 visits flare was identified by both
definitions. The overall concordance was 83.8% with kappa value of 0.45
suggesting moderate agreement (p =0.00001).  Applying minimum cut-offs for ACR core
variables, as done in randomized trials of polyarticular course JIA, only 278
visits would fulfill the criteria.  The Kaplan Meier curves are presented in
the figure.

 

Conclusion:  A flare definition based on PROs had moderate
concordance with the one based on ACR core set variables. It tended to
underestimate the risk of flare. The feasibility of using both the definitions
to define flare in this routine practice-based cohort was limited by missing
data requiring imputation and by study visits scheduled at set intervals.

 


Disclosure: V. Shivamurthy, None; D. M. Levy, None; G. Boire, None; K. N. Watanabe Duffy, None; E. Stringer, None; R. Scuccimarri, None; R. S. M. Yeung, Novartis Pharmaceutical Corporation, 2; A. M. Huber, None; K. Oen, None; N. Shiff, None; L. B. Tucker, None; R. Berard, None; K. Morishita, None; C. M. Duffy, None; J. Guzman, None.

To cite this abstract in AMA style:

Shivamurthy V, Levy DM, Boire G, Watanabe Duffy KN, Stringer E, Scuccimarri R, Yeung RSM, Huber AM, Oen K, Shiff N, Tucker LB, Berard R, Morishita K, Duffy CM, Guzman J. Flare Definitions for Juvenile Idiopathic Arthritis (JIA) Based on ACR Core Set Variables and Patient Reported Outcomes: Results from the Research in Arthritis in Canadian Children-Emphasizing Outcomes Prospective Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/flare-definitions-for-juvenile-idiopathic-arthritis-jia-based-on-acr-core-set-variables-and-patient-reported-outcomes-results-from-the-research-in-arthritis-in-canadian-children-emphasizing-outcome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/flare-definitions-for-juvenile-idiopathic-arthritis-jia-based-on-acr-core-set-variables-and-patient-reported-outcomes-results-from-the-research-in-arthritis-in-canadian-children-emphasizing-outcome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology